Pay in 4 interest-free payments of $5.83 Learn more
Ships within 48 hours · Estimated delivery Aug 28 - Sep 2
Zepbound (tirzepatide) is a novel glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist approved by the FDA in November 2023 for chronic weight management in adults with obesity or overweight with weight-related comorbidities
Lucie, FL 34952 Mon-Fri | 9 AM 5 PM Sat-Sun | Closed Holiday Hours Memorial Day: Closed July 4th: Closed Labor Day: Closed Thanksgiving: Closed Christmas: Closed New Years Day: Closed
The connection is mechanistic, not proven by direct evidence
Avoid sugary foods and drinks as they can spike your blood sugar levels
US$ 22.93
US$ 22.23
US$ 28.69
US$ 26.43
